Hematological Malignancies
US Intergroup Trial E2496 ABVD vs Stanford V in Advanced Stages
Failure – free Survival
1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0
Probability
5-year FFS
66% vs. 66%
0
1
2
3
4
5
6
7
8
9
10
Year
Treatment Code
fall
Not-Fall
MEDIAN
CONFTOTAL
, ,
80 79
183 180
Stanford V ABVD
263 259
Made with FlippingBook